389 related articles for article (PubMed ID: 25557802)
1. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.
Kamar N; Del Bello A; Belliere J; Rostaing L
Transpl Int; 2015 Aug; 28(8):928-37. PubMed ID: 25557802
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
Flechner SM; Kobashigawa J; Klintmalm G
Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
[TBL] [Abstract][Full Text] [Related]
3. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant.
Boswell A; Evans L; Rigg K; Shehata M
Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive minimization with mTOR inhibitors and belatacept.
Diekmann F
Transpl Int; 2015 Aug; 28(8):921-7. PubMed ID: 25959589
[TBL] [Abstract][Full Text] [Related]
6. The safety of calcineurin inhibitors for kidney-transplant patients.
Malvezzi P; Rostaing L
Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitor-free protocols: risks and benefits.
Barbari AG; Stephan AG; Masri MA
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
Baczkowska T; Durlik M
Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin-inhibitor-sparing immunosuppressive protocols.
Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3729-32. PubMed ID: 16386520
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitor avoidance and withdrawal for kidney transplantation: a systematic review and meta-analysis of randomized controlled trials.
Yan HL; Zong HT; Cui YS; Li N; Zhang Y
Transplant Proc; 2014 Jun; 46(5):1302-13. PubMed ID: 24935293
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.
Moore J; Middleton L; Cockwell P; Adu D; Ball S; Little MA; Ready A; Wheatley K; Borrows R
Transplantation; 2009 Feb; 87(4):591-605. PubMed ID: 19307799
[TBL] [Abstract][Full Text] [Related]
12. Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis.
Montero N; Quero M; Melilli E; Pérez-Sáez MJ; Redondo-Pachón D; Bestard O; Crespo M; Cruzado JM; Pascual J
Transplantation; 2019 Oct; 103(10):2031-2056. PubMed ID: 31343574
[TBL] [Abstract][Full Text] [Related]
13. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.
Xie X; Jiang Y; Lai X; Xiang S; Shou Z; Chen J
BMC Nephrol; 2015 Jul; 16():91. PubMed ID: 26126806
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor sparing in renal transplantation.
Ekberg H
Transplantation; 2008 Sep; 86(6):761-7. PubMed ID: 18813097
[TBL] [Abstract][Full Text] [Related]
16. Is the failure of recent trials on withdrawal of calcineurin inhibitors due to inadequate mycophenolic acid dosing?
Hellemans R; Abramowicz D
J Nephrol; 2022 Sep; 35(7):1789-1795. PubMed ID: 35088366
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation.
Haller M; Oberbauer R
Transpl Int; 2009 Jan; 22(1):69-77. PubMed ID: 18764837
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review.
Ponticelli C; Scolari MP
Transplant Proc; 2010; 42(6):2205-8. PubMed ID: 20692445
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitor minimization protocols in liver transplantation.
Farkas SA; Schnitzbauer AA; Kirchner G; Obed A; Banas B; Schlitt HJ
Transpl Int; 2009 Jan; 22(1):49-60. PubMed ID: 19121146
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression Minimization and Avoidance Protocols: When Less Is Not More.
Prashar R; Venkat KK
Adv Chronic Kidney Dis; 2016 Sep; 23(5):295-300. PubMed ID: 27742383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
